Pasar al contenido principal

ESTUDIO DE DIANAS NEUROANATOMICAS Y BIOLOGICAS COMUNES EN LA DISTONIA HEREDITARIA DE INICIO EN LA INFANCIA.

PI21/00248

•
Nombre agencia financiadora Instituto de Salud Carlos III
Acrónimo agencia financiadora ISCIII
Programa Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de Investigación en Salud
Año convocatoria 2021
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION INSTITUTO DE INVESTIGACION VALLE DE HEBRON
Centro realización INSTITUTO DE INVESTIGACION HOSPITAL UNIVERSITARIO VALLE DE HEBRON (VHIR)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 10
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Natural history of SGCE-associated myoclonus dystonia in children and adolescents

  • De Francesch, Valeria
  • Cazurro-Gutiérrez, Ana Laura|||0000-0002-2922-605X
  • Timmers, Elze R.
  • Español-Martín, Gemma|||0000-0002-2362-8189
  • Ferrero-Turrión, Julia
  • Gómez-Andrés, David|||0000-0001-5654-7791
  • Marcé-Grau, Anna|||0000-0001-5762-4023
  • Dougherty-De Miguel, Lucy|||0000-0002-8865-2438
  • González Soler, Victoria|||0000-0002-0983-2052
  • Moreno Galdó, Antonio|||0000-0002-2496-9786
  • Tijssen, Marina A. J.
  • Pérez-Dueñas, Belén|||0000-0002-4979-2788
Aim: To investigate the natural progression of SGCE-associated myoclonus dystonia from symptom onset in childhood to early adulthood. Method: Myoclonus and dystonia were monitored using rating scales in two cohorts of participants from Spain and the Netherlands. Individual annualized rates of change were calculated and longitudinal trends were assessed using Bayesian mixed models. Psychiatric features were evaluated cross-sectionally in the Spanish cohort. Results: Thirty-eight patients (21 males, 17 females) were evaluated at a mean age (SD) of 10 years (4 years 7 months; range 2-21 years) and 14 years 2 months (4 years 8 months; range 4-25 years). We observed a significant worsening of action myoclonus, global dystonia, and dystonia during writing (mean annual increases of 1.356, 0.226, and 0.518 in the Unified Myoclonus, Burke-Fahn-Marsden, and Writer's Cramp Rating Scales respectively). Accordingly, participants perceived a significant worsening in their speech, writing, and walking abilities. Twenty-six of 32 participants suffered from anxiety (n = 13), obsessive-compulsive disorder (n = 9), and attention-deficit/hyperactivity disorder (n = 8). Interpretation: This study demonstrates that, unlike in the adult population, myoclonus dystonia syndrome in childhood and adolescence follows a progressive course that can be debilitating in the early stages of life. These findings, along with a high prevalence of psychiatric symptoms, highlight the need for early therapeutic interventions to prevent long-term motor and psychological sequelae.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A Case of Hyperinsulinemic Hypoglycaemia Associated with Atypical Fanconi Renal Tubulopathy Syndrome Caused by an HNF4A Variant

  • Garriga-Edo, Sarai
  • Peris-Serra, Lydia
  • Ríos Duro, Héctor
  • Giralt, Marina
  • Díaz-Troyano, Noelia|||0000-0002-9392-0142
  • Ferrer, Roser
  • Ferrer, Roser
  • Antolín, María|||0000-0001-5623-6862
  • Pérez Dueñas, Belén
  • Clemente, Maria|||0000-0002-3721-5043
Introduction: This case illustrates the challenges in the diagnosis of a rare disease with an intricate orientation. The definitive genetic diagnosis was carried out after establishing crucial correlations between the preliminary clinical indications and the laboratory findings. Case Presentation: The initial presentation was myoclonic jerks. This was a direct consequence of hyperinsulinaemic hypoglycaemia (HH), and not a phenotypic characteristic described in previous case reports. Linking this to glycaemia led to the evaluation of response to fasting, where inadequate insulin suppression resulted in hypoketotic hypoglycaemia. The diagnosis of chronic kidney dysfunction associated with atypical Fanconi renal tubulopathy syndrome type 4 (FRTS4) was indicated on the basis of a decreased estimated glomerular filtration rate, nephrocalcinosis, millimetric lithiasis, rickets, and complex proximal tubulopathy. This indicated atypical FRTS4 as associated with HH and necessitated further molecular genetic testing. Conclusion: The patient was identified as a carrier of the c.187C>T (p.Arg63Trp) variant in the HNF4A gene, which is a heterozygous missense variant classified as pathogenic. This entity is rare, and the published literature reporting HNF4A gene variants associated with atypical FRTS and HH is limited. It is therefore important to report such cases to contribute to the growing body of evidence and help identify pathogenic HNF4A variants and their implications.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Deep Brain Stimulation in Children and Adolescents with ε-Sarcoglycan Myoclonus Dystonia Causes a Sustained Improvement in Motor Functionality and Quality of Life

  • Salazar-Villacorta, Ainara
  • Folch-Benito, Marta
  • Lucero-Garófano, Álvaro
  • Macaya Ruíz, Alfons
  • Loredo, Martha
  • Toro Tamargo, Esther
  • Figueroa Vezirián, Margarita
  • Cazurro Gutiérrez, Ana Laura
  • Dougherty-de Miguel, Lucia
  • Ferrero-Turrion, Julia
  • Marcé-Grau, Anna
  • GONZALEZ, Victoria
  • Español Martin, Gemma
  • Delgado Alvarez, Ignacio
  • Bescós, Agustín
  • PEREZ DUEÑAS, BELEN
  • Moreno-Galdó, Antonio
Estimulación cerebral profunda; Distonía mioclónica; Calidad de vida, Deep brain stimulation; Myoclonus dystonia; Quality of Life, Estimulació cerebral profunda; Distonia mioclònica; Qualitat de vida, Background Deep brain stimulation of the globus pallidus internus (DBS-GPi) has shown efficacy in adult patients with SGCE-related myoclonus dystonia. However, evidence regarding its impact in pediatric populations is limited. Objectives The aim was to evaluate motor and non-motor outcomes following DBS-GPi intervention in children and adolescents with SGCE-MD. Methods Ten patients (mean age 12.8 ± 3.4 years) underwent DBS-GPi. Blinded experts rated patients with the Unified Myoclonus, Burke-Fahn-Marsden, Writer's cramp and Gait Dystonia rating scales. Psychiatric and quality-of-life outcomes were evaluated using the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition criteria and Quality of Life in Neurological Disorders. Results Significant improvements were observed in myoclonus (68.1%), generalized dystonia (63.2%), and dystonia during writing (48.1%), walking (70.3%) and running (44.2%) after 3.8 ± 2.4 years of the surgery. Psychiatric symptoms remained stable, while quality-of-life assessments revealed reductions in anxiety, fatigue, and stigma (P < 0.05). Conclusions DBS-GPi in children with SGCE-myoclonus dystonia mitigates long-term disability, potentially enhancing academic, social, and professional prospects., The authors declare no potential conflict of interest with the present work. This work was supported by Instituto de Salud Carlos III (grant numbers PI21/00248, PI24/01083, and FORT23/00034) and the Boston Scientific Corporation (grant number PR[AMI]481/2021). A.S.V. was supported by La Caixa Postgraduate Abroad fellowship. A.C.G. was supported by the Agency for Management of University and Research Grants, AGAUR (2022 FI_B 00996). A.M.G. is granted a postdoctoral contract funded by Instituto de Salud Carlos III (ISCIII) through the project FORT23/00034.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The Genetic Landscape of Complex Childhood-Onset Hyperkinetic Movement Disorders

  • Gorman, Kathleen
  • Marcé Grau, Anna
  • Danti, Federica Rachele
  • Perez Dueñas, Belen
  • Ortigoza Escobar, Juan Dario
  • Macaya Ruíz, Alfons
Dystonia; Hyperkinetic movement disorders; Infantile parkinsonis, Distonía; Trastornos del movimiento hipercinético; Parkinsonismo infantil, Distonia; Trastorns del moviment hipercinètic; Parkinsonisme infantil, Background and Objective The objective of this study was to better delineate the genetic landscape and key clinical characteristics of complex, early-onset, monogenic hyperkinetic movement disorders. Methods Patients were recruited from 14 international centers. Participating clinicians completed standardized proformas capturing demographic, clinical, and genetic data. Two pediatric movement disorder experts reviewed available video footage, classifying hyperkinetic movements according to published criteria. Results One hundred forty patients with pathogenic variants in 17 different genes (ADCY5, ATP1A3, DDC, DHPR, FOXG1, GCH1, GNAO1, KMT2B, MICU1, NKX2.1, PDE10A, PTPS, SGCE, SLC2A1, SLC6A3, SPR, and TH) were identified. In the majority, hyperkinetic movements were generalized (77%), with most patients (69%) manifesting combined motor semiologies. Parkinsonism-dystonia was characteristic of primary neurotransmitter disorders (DDC, DHPR, PTPS, SLC6A3, SPR, TH); chorea predominated in ADCY5-, ATP1A3-, FOXG1-, NKX2.1-, SLC2A1-, GNAO1-, and PDE10A-related disorders; and stereotypies were a prominent feature in FOXG1- and GNAO1-related disease. Those with generalized hyperkinetic movements had an earlier disease onset than those with focal/segmental distribution (2.5 ± 0.3 vs. 4.7 ± 0.7 years; P = 0.007). Patients with developmental delay also presented with hyperkinetic movements earlier than those with normal neurodevelopment (1.5 ± 2.9 vs. 4.7 ± 3.8 years; P < 0.001). Effective disease-specific therapies included dopaminergic agents for neurotransmitters disorders, ketogenic diet for glucose transporter deficiency, and deep brain stimulation for SGCE-, KMT2B-, and GNAO1-related hyperkinesia. Conclusions This study highlights the complex phenotypes observed in children with genetic hyperkinetic movement disorders that can lead to diagnostic difficulty. We provide a comprehensive analysis of motor semiology to guide physicians in the genetic investigation of these patients, to facilitate early diagnosis, precision medicine treatments, and genetic counseling. © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society., This work was supported by an NIHR Professorship (to M.A.K.). M.A.K. has received funding from the Sir Jules Thorn Award for Biomedical Research and Wellcome Trust. B.P.-D. was supported by Instituto de Salud Carlos III, PI 18/01319 and PI21/00248, and has received funding from Beca José Castillejos (CAS14/00328). K.J.P. was supported by an MRC Clinician–Scientist Fellowship (511015) and was supported by the Dystonia Medical Research Foundation and Fight for Sight. S.S.M. has received funding from the Winston Churchill Memorial trust and Cerebral Palsy Alliance.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Natural history of SGCE-associated myoclonus dystonia in children and adolescents

  • De Francesch, Valeria
  • Timmers, Elze
  • Español Martín, Gemma
  • Ferrero-Turrion, Julia
  • Gómez Andrés, David
  • Marcé-Grau, Anna
  • Dougherty-de Miguel, Lucia
  • Gonzalez Martinez, Maria Victoria
  • Cazurro Gutiérrez, Ana Laura
  • PEREZ DUEÑAS, BELEN
  • Moreno-Galdó, Antonio
Myoclonus dystonia; Children, Distonía mioclónica; Niños, Distonia mioclònica; Nens, Aim: To investigate the natural progression of SGCE-associated myoclonus dystonia from symptom onset in childhood to early adulthood. Method: Myoclonus and dystonia were monitored using rating scales in two cohorts of participants from Spain and the Netherlands. Individual annualized rates of change were calculated and longitudinal trends were assessed using Bayesian mixed models. Psychiatric features were evaluated cross-sectionally in the Spanish cohort. Results: Thirty-eight patients (21 males, 17 females) were evaluated at a mean age (SD) of 10 years (4 years 7 months; range 2-21 years) and 14 years 2 months (4 years 8 months; range 4-25 years). We observed a significant worsening of action myoclonus, global dystonia, and dystonia during writing (mean annual increases of 1.356, 0.226, and 0.518 in the Unified Myoclonus, Burke-Fahn-Marsden, and Writer's Cramp Rating Scales respectively). Accordingly, participants perceived a significant worsening in their speech, writing, and walking abilities. Twenty-six of 32 participants suffered from anxiety (n = 13), obsessive-compulsive disorder (n = 9), and attention-deficit/hyperactivity disorder (n = 8). Interpretation: This study demonstrates that, unlike in the adult population, myoclonus dystonia syndrome in childhood and adolescence follows a progressive course that can be debilitating in the early stages of life. These findings, along with a high prevalence of psychiatric symptoms, highlight the need for early therapeutic interventions to prevent long-term motor and psychological sequelae., Myoclonus Dystonia Spanish association (ALUDME). Grant Numbers: FORT23/00034, PI24/01083, PI21/00248. Agència de Gestió d'Ajuts Universitaris i de Recerca. Grant Number: 2022 FI_B 00996. Instituto de Salud Carlos III. Grant Numbers: FORT23/00034, PI21/00248, PI24/01083.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The Genetic Landscape of Complex Childhood-Onset Hyperkinetic Movement Disorders

  • Pérez-Dueñas, Belén|||0000-0002-4979-2788
  • Gorman, Kathleen
  • Marcé-Grau, Anna|||0000-0001-5762-4023
  • Ortigoza-Escobar, Juan D.
  • Macaya Ruiz, Alfons|||0000-0001-7998-4185
  • Danti, Federica R.
  • Barwick, Katy
  • Papandreou, Apostolos|||0000-0001-5093-6075
  • Ng, Joanne
  • Meyer, Esther
  • Mohammad, Shekeeb S.|||0000-0003-1219-4781
  • Smith, Martin
  • Muntoni, Francesco
  • Munot, Pinki
  • Uusimaa, Johanna
  • Vieira, Päivi
  • Sheridan, Eammon
  • Guerrini, Renzo
  • Cobben, Jan
  • Yilmaz, Sanem
  • De Grandis, Elisa
  • Dale, Russell C..
  • Pons, Roser|||0000-0001-6749-1906
  • Peall, Kathryn J.|||0000-0003-4749-4944
  • Leuzzi, Vincenzo
  • Kurian, Manju A.|||0000-0003-3529-5075
Background and Objective: The objective of this study was to better delineate the genetic landscape and key clinical characteristics of complex, early-onset, monogenic hyperkinetic movement disorders. Methods: Patients were recruited from 14 international centers. Participating clinicians completed standardized proformas capturing demographic, clinical, and genetic data. Two pediatric movement disorder experts reviewed available video footage, classifying hyperkinetic movements according to published criteria. Results: One hundred forty patients with pathogenic variants in 17 different genes (ADCY5, ATP1A3, DDC, DHPR, FOXG1, GCH1, GNAO1, KMT2B, MICU1, NKX2.1, PDE10A, PTPS, SGCE, SLC2A1, SLC6A3, SPR, and TH) were identified. In the majority, hyperkinetic movements were generalized (77%), with most patients (69%) manifesting combined motor semiologies. Parkinsonism-dystonia was characteristic of primary neurotransmitter disorders (DDC, DHPR, PTPS, SLC6A3, SPR, TH); chorea predominated in ADCY5-, ATP1A3-, FOXG1-, NKX2.1-, SLC2A1-, GNAO1-, and PDE10A-related disorders; and stereotypies were a prominent feature in FOXG1- and GNAO1-related disease. Those with generalized hyperkinetic movements had an earlier disease onset than those with focal/segmental distribution (2.5 ± 0.3 vs. 4.7 ± 0.7 years; P = 0.007). Patients with developmental delay also presented with hyperkinetic movements earlier than those with normal neurodevelopment (1.5 ± 2.9 vs. 4.7 ± 3.8 years; P < 0.001). Effective disease-specific therapies included dopaminergic agents for neurotransmitters disorders, ketogenic diet for glucose transporter deficiency, and deep brain stimulation for SGCE-, KMT2B-, and GNAO1-related hyperkinesia. Conclusions: This study highlights the complex phenotypes observed in children with genetic hyperkinetic movement disorders that can lead to diagnostic difficulty. We provide a comprehensive analysis of motor semiology to guide physicians in the genetic investigation of these patients, to facilitate early diagnosis, precision medicine treatments, and genetic counseling. © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The Expanding Phenotypical Spectrum of WARS2 -Related Disorder, Four Novel Cases with a Common Recurrent Variant

  • Pauly, Martje G.|||0000-0002-7794-0282
  • Korenke, G. Christoph
  • Diaw, Sokhna Haissatou
  • Grözinger, Anne
  • Cazurro-Gutiérrez, Ana Laura|||0000-0002-2922-605X
  • Pérez-Dueñas, Belén|||0000-0002-4979-2788
  • González Martínez, María Victoria
  • Macaya Ruiz, Alfons|||0000-0001-7998-4185
  • Serrano Antón, Ana Teresa|||0000-0001-5471-8550
  • Peterlin, Borut|||0000-0001-7824-4978
  • Božović, Ivana Babić
  • Maver, Ales
  • Münchau, Alexander
  • Lohmann, Katja|||0000-0002-5121-1460
Biallelic variants in the mitochondrial form of the tryptophanyl-tRNA synthetases (WARS2) can cause a neurodevelopmental disorder with movement disorders including early-onset tremor-parkinsonism syndrome. Here, we describe four new patients, who all presented at a young age with a tremor-parkinsonism syndrome and responded well to levodopa. All patients carry the same recurrent, hypomorphic missense variant (NM_015836.4: c.37T.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Deep Brain Stimulation in Children and Adolescents with ε-Sarcoglycan Myoclonus Dystonia Causes a Sustained Improvement in Motor Functionality and Quality of Life

  • Salazar-Villacorta, Ainara
  • Folch-Benito, Marta
  • Lucero-Garófano, Álvaro
  • Macaya Ruíz, Alfons
  • Loredo, Martha
  • Toro Tamargo, Esther
  • Figueroa Vezirián, Margarita
  • Cazurro Gutiérrez, Ana Laura
  • Dougherty-de Miguel, Lucia
  • Ferrero-Turrion, Julia
  • Marcé-Grau, Anna
  • GONZALEZ, Victoria
  • Español Martin, Gemma
  • Delgado Alvarez, Ignacio
  • Bescós, Agustín
  • PEREZ DUEÑAS, BELEN
  • Moreno-Galdó, Antonio
Estimulación cerebral profunda; Distonía mioclónica; Calidad de vida, Deep brain stimulation; Myoclonus dystonia; Quality of Life, Estimulació cerebral profunda; Distonia mioclònica; Qualitat de vida, Background Deep brain stimulation of the globus pallidus internus (DBS-GPi) has shown efficacy in adult patients with SGCE-related myoclonus dystonia. However, evidence regarding its impact in pediatric populations is limited. Objectives The aim was to evaluate motor and non-motor outcomes following DBS-GPi intervention in children and adolescents with SGCE-MD. Methods Ten patients (mean age 12.8 ± 3.4 years) underwent DBS-GPi. Blinded experts rated patients with the Unified Myoclonus, Burke-Fahn-Marsden, Writer's cramp and Gait Dystonia rating scales. Psychiatric and quality-of-life outcomes were evaluated using the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition criteria and Quality of Life in Neurological Disorders. Results Significant improvements were observed in myoclonus (68.1%), generalized dystonia (63.2%), and dystonia during writing (48.1%), walking (70.3%) and running (44.2%) after 3.8 ± 2.4 years of the surgery. Psychiatric symptoms remained stable, while quality-of-life assessments revealed reductions in anxiety, fatigue, and stigma (P < 0.05). Conclusions DBS-GPi in children with SGCE-myoclonus dystonia mitigates long-term disability, potentially enhancing academic, social, and professional prospects., The authors declare no potential conflict of interest with the present work. This work was supported by Instituto de Salud Carlos III (grant numbers PI21/00248, PI24/01083, and FORT23/00034) and the Boston Scientific Corporation (grant number PR[AMI]481/2021). A.S.V. was supported by La Caixa Postgraduate Abroad fellowship. A.C.G. was supported by the Agency for Management of University and Research Grants, AGAUR (2022 FI_B 00996). A.M.G. is granted a postdoctoral contract funded by Instituto de Salud Carlos III (ISCIII) through the project FORT23/00034.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Natural history of SGCE-associated myoclonus dystonia in children and adolescents

  • De Francesch, Valeria
  • Timmers, Elze
  • Español Martín, Gemma
  • Ferrero-Turrion, Julia
  • Gómez Andrés, David
  • Marcé-Grau, Anna
  • Dougherty-de Miguel, Lucia
  • Gonzalez Martinez, Maria Victoria
  • Cazurro Gutiérrez, Ana Laura
  • PEREZ DUEÑAS, BELEN
  • Moreno-Galdó, Antonio
Myoclonus dystonia; Children, Distonía mioclónica; Niños, Distonia mioclònica; Nens, Aim: To investigate the natural progression of SGCE-associated myoclonus dystonia from symptom onset in childhood to early adulthood. Method: Myoclonus and dystonia were monitored using rating scales in two cohorts of participants from Spain and the Netherlands. Individual annualized rates of change were calculated and longitudinal trends were assessed using Bayesian mixed models. Psychiatric features were evaluated cross-sectionally in the Spanish cohort. Results: Thirty-eight patients (21 males, 17 females) were evaluated at a mean age (SD) of 10 years (4 years 7 months; range 2-21 years) and 14 years 2 months (4 years 8 months; range 4-25 years). We observed a significant worsening of action myoclonus, global dystonia, and dystonia during writing (mean annual increases of 1.356, 0.226, and 0.518 in the Unified Myoclonus, Burke-Fahn-Marsden, and Writer's Cramp Rating Scales respectively). Accordingly, participants perceived a significant worsening in their speech, writing, and walking abilities. Twenty-six of 32 participants suffered from anxiety (n = 13), obsessive-compulsive disorder (n = 9), and attention-deficit/hyperactivity disorder (n = 8). Interpretation: This study demonstrates that, unlike in the adult population, myoclonus dystonia syndrome in childhood and adolescence follows a progressive course that can be debilitating in the early stages of life. These findings, along with a high prevalence of psychiatric symptoms, highlight the need for early therapeutic interventions to prevent long-term motor and psychological sequelae., Myoclonus Dystonia Spanish association (ALUDME). Grant Numbers: FORT23/00034, PI24/01083, PI21/00248. Agència de Gestió d'Ajuts Universitaris i de Recerca. Grant Number: 2022 FI_B 00996. Instituto de Salud Carlos III. Grant Numbers: FORT23/00034, PI21/00248, PI24/01083.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

The Genetic Landscape of Complex Childhood-Onset Hyperkinetic Movement Disorders

  • Gorman, Kathleen
  • Marcé Grau, Anna
  • Danti, Federica Rachele
  • Perez Dueñas, Belen
  • Ortigoza Escobar, Juan Dario
  • Macaya Ruíz, Alfons
Dystonia; Hyperkinetic movement disorders; Infantile parkinsonis, Distonía; Trastornos del movimiento hipercinético; Parkinsonismo infantil, Distonia; Trastorns del moviment hipercinètic; Parkinsonisme infantil, Background and Objective The objective of this study was to better delineate the genetic landscape and key clinical characteristics of complex, early-onset, monogenic hyperkinetic movement disorders. Methods Patients were recruited from 14 international centers. Participating clinicians completed standardized proformas capturing demographic, clinical, and genetic data. Two pediatric movement disorder experts reviewed available video footage, classifying hyperkinetic movements according to published criteria. Results One hundred forty patients with pathogenic variants in 17 different genes (ADCY5, ATP1A3, DDC, DHPR, FOXG1, GCH1, GNAO1, KMT2B, MICU1, NKX2.1, PDE10A, PTPS, SGCE, SLC2A1, SLC6A3, SPR, and TH) were identified. In the majority, hyperkinetic movements were generalized (77%), with most patients (69%) manifesting combined motor semiologies. Parkinsonism-dystonia was characteristic of primary neurotransmitter disorders (DDC, DHPR, PTPS, SLC6A3, SPR, TH); chorea predominated in ADCY5-, ATP1A3-, FOXG1-, NKX2.1-, SLC2A1-, GNAO1-, and PDE10A-related disorders; and stereotypies were a prominent feature in FOXG1- and GNAO1-related disease. Those with generalized hyperkinetic movements had an earlier disease onset than those with focal/segmental distribution (2.5 ± 0.3 vs. 4.7 ± 0.7 years; P = 0.007). Patients with developmental delay also presented with hyperkinetic movements earlier than those with normal neurodevelopment (1.5 ± 2.9 vs. 4.7 ± 3.8 years; P < 0.001). Effective disease-specific therapies included dopaminergic agents for neurotransmitters disorders, ketogenic diet for glucose transporter deficiency, and deep brain stimulation for SGCE-, KMT2B-, and GNAO1-related hyperkinesia. Conclusions This study highlights the complex phenotypes observed in children with genetic hyperkinetic movement disorders that can lead to diagnostic difficulty. We provide a comprehensive analysis of motor semiology to guide physicians in the genetic investigation of these patients, to facilitate early diagnosis, precision medicine treatments, and genetic counseling. © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society., This work was supported by an NIHR Professorship (to M.A.K.). M.A.K. has received funding from the Sir Jules Thorn Award for Biomedical Research and Wellcome Trust. B.P.-D. was supported by Instituto de Salud Carlos III, PI 18/01319 and PI21/00248, and has received funding from Beca José Castillejos (CAS14/00328). K.J.P. was supported by an MRC Clinician–Scientist Fellowship (511015) and was supported by the Dystonia Medical Research Foundation and Fight for Sight. S.S.M. has received funding from the Winston Churchill Memorial trust and Cerebral Palsy Alliance.